Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEQUEL: VI-0521 Extension in Obesity
NCT00796367Phase 3Completed
- Sponsor
- VIVUS
- Start
- Dec 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of phentermine + topiramate in obesity, Overweight, sponsored by VIVUS. Started Dec 2008; status: completed.
02
Drugs
phentermine + topiramate
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT00796367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796367.